So satisfying to see a long journey end in best-possible diagnostic test for patients with rare diseases @radboudumc.bsky.social.
www.radboudumc.nl/en/news-item...
(1/n)
So satisfying to see a long journey end in best-possible diagnostic test for patients with rare diseases @radboudumc.bsky.social.
www.radboudumc.nl/en/news-item...
(1/n)
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Our latest manuscript is now live on bioRxiv:
"The Neuronal Primary Cilium is a Key Regulator of Homeostatic Plasticity"
We hope you enjoy reading it!
www.biorxiv.org/content/10.1...
Our latest manuscript is now live on bioRxiv:
"The Neuronal Primary Cilium is a Key Regulator of Homeostatic Plasticity"
We hope you enjoy reading it!
www.biorxiv.org/content/10.1...
Excited to share our latest study, now live on bioRxiv:
"The NSL Complex Promotes Neural Development by Preventing R-Loop Induced Replication Stress"
www.biorxiv.org/content/10.1...
Excited to share our latest study, now live on bioRxiv:
"The NSL Complex Promotes Neural Development by Preventing R-Loop Induced Replication Stress"
www.biorxiv.org/content/10.1...
By @psudmant.bsky.social and colleagues
🧪🧬
www.biorxiv.org/content/10.1...
By @psudmant.bsky.social and colleagues
🧪🧬
www.biorxiv.org/content/10.1...
We’re thrilled to announce our keynote speaker @sergiuppasca.bsky.social
📅 Event date: September 19, 2025
📍 Location: Erasmus MC Rotterdam
🔗 Register now: www.neurodevdisorders.org
We’re thrilled to announce our keynote speaker @sergiuppasca.bsky.social
📅 Event date: September 19, 2025
📍 Location: Erasmus MC Rotterdam
🔗 Register now: www.neurodevdisorders.org
genomemedicine.biomedcentral.com/articles/10....
genomemedicine.biomedcentral.com/articles/10....
at #neurogen25
@nereokalebic.bsky.social @harschnitz.bsky.social @humantechnopole.bsky.social
@r3rt0.bsky.social
at #neurogen25
@nereokalebic.bsky.social @harschnitz.bsky.social @humantechnopole.bsky.social
@r3rt0.bsky.social
at #neurogen25
@nereokalebic.bsky.social @harschnitz.bsky.social
@humantechnopole.bsky.social
@r3rt0.bsky.social
at #neurogen25
@nereokalebic.bsky.social @harschnitz.bsky.social
@humantechnopole.bsky.social
@r3rt0.bsky.social
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
We performed a systematic analysis of genetic and phenotypic characteristics to identify potential candidate neurodevelopmental disorders amenable for antisense
oligonucleotide therapy.
Kudos to PhD student Kim Wijnant
www.biorxiv.org/content/10.1...
We performed a systematic analysis of genetic and phenotypic characteristics to identify potential candidate neurodevelopmental disorders amenable for antisense
oligonucleotide therapy.
Kudos to PhD student Kim Wijnant
www.biorxiv.org/content/10.1...
Here’s what we discovered 👇
www.biorxiv.org/content/10.1...
Here’s what we discovered 👇
www.biorxiv.org/content/10.1...
genetic diversity #evolution #disease
www.biorxiv.org/content/10.1...
genetic diversity #evolution #disease
www.biorxiv.org/content/10.1...
PhD position in now open
www.radboudumc.nl/en/vacancies...
PhD position in now open
www.radboudumc.nl/en/vacancies...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...